Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184 Buy
3
+1
+50% +$61 ﹤0.01% 393
2026
Q1
$139 Hold
2
﹤0.01% 381
2025
Q4
$152 Sell
2
-2
-50% -$161 ﹤0.01% 378
2025
Q3
$345 Hold
4
﹤0.01% 342
2025
Q2
$273 Sell
4
-1
-20% -$62 ﹤0.01% 338
2025
Q1
$298 Buy
+5
New +$317 ﹤0.01% 316
2024
Q4
Sell
-2
Closed -$144 346
2024
Q3
$144 Hold
2
﹤0.01% 329
2024
Q2
$141 Hold
2
﹤0.01% 295
2024
Q1
$159 Hold
2
﹤0.01% 264
2023
Q4
$179 Hold
2
﹤0.01% 242
2023
Q3
$197 Buy
+2
New +$207 ﹤0.01% 233
2023
Q1
Sell
-2
Closed -$221 224
2022
Q4
$186 Hold
2
﹤0.01% 231
2022
Q3
$0 Hold
2
﹤0.01% 150
2022
Q2
$178 Buy
+2
New +$204 ﹤0.01% 226
2022
Q1
Sell
-2
Closed -$266 213
2021
Q4
$329 Buy
+2
New +$334 ﹤0.01% 200
2021
Q3
Hold
0
195
2021
Q2
Hold
0
192

Other funds holding APTV

WestEnd Advisors's APTV Position: Q2 2026 in Review

WestEnd Advisors increased its Aptiv (APTV) stake by 50% in Q2 2026, buying an estimated $61 and bringing the position to 3 shares worth $184. The position accounts for ﹤0.01% of the portfolio, ranked #393.

WestEnd Advisors first reported a position in APTV in Q4 2021 and has held it in 15 quarters since. The position peaked at $345 in Q3 2025. 137 funds tracked by Wall St. Rank hold APTV as of Q2 2026.

  • WestEnd Advisors held 3 shares of Aptiv worth $184 as of Q2 2026.
  • WestEnd Advisors bought 1 Aptiv share in Q2 2026, an estimated $61.
  • Aptiv made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #393 holding.
  • WestEnd Advisors first reported a position in Aptiv in Q4 2021 and has held it in 15 quarters since.
  • WestEnd Advisors's Aptiv position peaked at $345 in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Aptiv as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.